Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Effectiveness of Palivizumab against Respiratory Syncytial Virus: Cohort and Case Series Analysis.

Moore HC, de Klerk N, Richmond PC, Fathima P, Xu R, Keil AD, Snelling TL, Strunk T.

J Pediatr. 2019 Aug 1. pii: S0022-3476(19)30822-4. doi: 10.1016/j.jpeds.2019.06.058. [Epub ahead of print]

PMID:
31378522
2.

Australian Aboriginal children have higher hospitalization rates for otitis media but lower surgical procedures than non-Aboriginal children: A record linkage population-based cohort study.

Westphal DW, Lehmann D, Williams SA, Richmond PC, Lannigan FJ, Fathima P, Blyth CC, Moore HC.

PLoS One. 2019 Apr 23;14(4):e0215483. doi: 10.1371/journal.pone.0215483. eCollection 2019.

3.

Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children.

Bhuiyan MU, Blyth CC, West R, Lang J, Rahman T, Granland C, de Gier C, Borland ML, Thornton RB, Kirkham LS, Martin A, Richmond PC, Smith DW, Jaffe A, Snelling TL.

BMC Pulm Med. 2019 Apr 2;19(1):71. doi: 10.1186/s12890-019-0835-5.

4.

Dynamic molecular changes during the first week of human life follow a robust developmental trajectory.

Lee AH, Shannon CP, Amenyogbe N, Bennike TB, Diray-Arce J, Idoko OT, Gill EE, Ben-Othman R, Pomat WS, van Haren SD, Cao KL, Cox M, Darboe A, Falsafi R, Ferrari D, Harbeson DJ, He D, Bing C, Hinshaw SJ, Ndure J, Njie-Jobe J, Pettengill MA, Richmond PC, Ford R, Saleu G, Masiria G, Matlam JP, Kirarock W, Roberts E, Malek M, Sanchez-Schmitz G, Singh A, Angelidou A, Smolen KK; EPIC Consortium, Brinkman RR, Ozonoff A, Hancock REW, van den Biggelaar AHJ, Steen H, Tebbutt SJ, Kampmann B, Levy O, Kollmann TR.

Nat Commun. 2019 Mar 12;10(1):1092. doi: 10.1038/s41467-019-08794-x.

5.

PCV7- and PCV10-Vaccinated Otitis-Prone Children in New Zealand Have Similar Pneumococcal and Haemophilus influenzae Densities in Their Nasopharynx and Middle Ear.

de Gier C, Granland CM, Pickering JL, Walls T, Bhuiyan M, Mills N, Richmond PC, Best EJ, Thornton RB, Kirkham LS.

Vaccines (Basel). 2019 Jan 31;7(1). pii: E14. doi: 10.3390/vaccines7010014.

6.

The contribution of viruses and bacteria to community-acquired pneumonia in vaccinated children: a case-control study.

Bhuiyan MU, Snelling TL, West R, Lang J, Rahman T, Granland C, de Gier C, Borland ML, Thornton RB, Kirkham LS, Sikazwe C, Martin AC, Richmond PC, Smith DW, Jaffe A, Blyth CC.

Thorax. 2019 Mar;74(3):261-269. doi: 10.1136/thoraxjnl-2018-212096. Epub 2018 Oct 18.

7.

Safety and Immunogenicity of Pneumococcal Conjugate Vaccines in a High-risk Population: A Randomized Controlled Trial of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccine in Papua New Guinean Infants.

Pomat WS, van den Biggelaar AHJ, Wana S, Francis JP, Solomon V, Greenhill AR, Ford R, Orami T, Passey M, Jacoby P, Kirkham LA, Lehmann D, Richmond PC; 10v13v PCV Trial Team .

Clin Infect Dis. 2019 Apr 24;68(9):1472-1481. doi: 10.1093/cid/ciy743.

8.

Severe and Complicated Varicella and Associated Genotypes 10 Years After Introduction of a One-Dose Varicella Vaccine Program.

Marshall HS, Clarke M, Heath C, Quinn H, Richmond PC, Crawford N, Elliott E, Toi C, Kynaston A, Booy R, Macartney K; PAEDS Investigators.

J Infect Dis. 2019 Jan 9;219(3):391-399. doi: 10.1093/infdis/jiy518.

PMID:
30184182
9.

The impact of influenza infection on young children, their family and the health care system.

Willis GA, Preen DB, Richmond PC, Jacoby P, Effler PV, Smith DW, Robins C, Borland ML, Levy A, Keil AD, Blyth CC; WAIVE Study Team.

Influenza Other Respir Viruses. 2019 Jan;13(1):18-27. doi: 10.1111/irv.12604. Epub 2018 Sep 11.

10.

Evidence of functional cell-mediated immune responses to nontypeable Haemophilus influenzae in otitis-prone children.

Seppanen E, Tan D, Corscadden KJ, Currie AJ, Richmond PC, Thornton RB, Kirkham LS.

PLoS One. 2018 Apr 5;13(4):e0193962. doi: 10.1371/journal.pone.0193962. eCollection 2018.

11.

Role of viral and bacterial pathogens in causing pneumonia among Western Australian children: a case-control study protocol.

Bhuiyan MU, Snelling TL, West R, Lang J, Rahman T, Borland ML, Thornton R, Kirkham LA, Sikazwe C, Martin AC, Richmond PC, Smith DW, Jaffe A, Blyth CC.

BMJ Open. 2018 Mar 16;8(3):e020646. doi: 10.1136/bmjopen-2017-020646.

12.

Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea.

Lehmann D, Kirarock W, van den Biggelaar AHJ, Passey M, Jacoby P, Saleu G, Masiria G, Nivio B, Greenhill A, Orami T, Francis J, Ford R, Kirkham LA, Solomon V, Richmond PC, Pomat WS; 10v13v PCV trial team.

Pneumonia (Nathan). 2017 Dec 25;9:20. doi: 10.1186/s41479-017-0044-z. eCollection 2017.

13.

Epidemiology of invasive meningococcal B disease in Australia, 1999-2015: priority populations for vaccination.

Archer BN, Chiu CK, Jayasinghe SH, Richmond PC, McVernon J, Lahra MM, Andrews RM, McIntyre PB; Australian Technical Advisory Group on Immunisation (ATAGI) Meningococcal Working Party.

Med J Aust. 2017 Nov 6;207(9):382-387.

PMID:
29092704
14.

Differences in the population structure of Neisseria meningitidis in two Australian states: Victoria and Western Australia.

Mowlaboccus S, Mullally CA, Richmond PC, Howden BP, Stevens K, Speers DJ, Keil AD, Bjørnstad ON, Perkins TT, Kahler CM.

PLoS One. 2017 Oct 24;12(10):e0186839. doi: 10.1371/journal.pone.0186839. eCollection 2017.

15.

Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination.

van den Biggelaar AHJ, Richmond PC, Fuery A, Anderson D, Opa C, Saleu G, Lai M, Francis JP, Alpers MP, Pomat WS, Lehmann D.

PLoS One. 2017 Oct 13;12(10):e0185877. doi: 10.1371/journal.pone.0185877. eCollection 2017.

16.

Replication and Excretion of the Live Attenuated Tetravalent Dengue Vaccine CYD-TDV in a Flavivirus-Naive Adult Population: Assessment of Vaccine Viremia and Virus Shedding.

Torresi J, Richmond PC, Heron LG, Qiao M, Marjason J, Starr-Spires L, van der Vliet D, Jin J, Wartel TA, Bouckenooghe A.

J Infect Dis. 2017 Oct 17;216(7):834-841. doi: 10.1093/infdis/jix314.

PMID:
28968794
17.

A longitudinal study of natural antibody development to pneumococcal surface protein A families 1 and 2 in Papua New Guinean Highland children: a cohort study.

Francis JP, Richmond PC, Michael A, Siba PM, Jacoby P, Hales BJ, Thomas WR, Lehmann D, Pomat WS, van den Biggelaar AHJ.

Pneumonia (Nathan). 2016 Aug 15;8:12. doi: 10.1186/s41479-016-0014-x. eCollection 2016.

18.

Immunogenicity and safety of single-dose, 13-valent pneumococcal conjugate vaccine in pediatric and adolescent oncology patients.

Hung TY, Kotecha RS, Blyth CC, Steed SK, Thornton RB, Ryan AL, Cole CH, Richmond PC.

Cancer. 2017 Nov 1;123(21):4215-4223. doi: 10.1002/cncr.30764. Epub 2017 Jul 11.

19.

Australian Aboriginal Children with Otitis Media Have Reduced Antibody Titers to Specific Nontypeable Haemophilus influenzae Vaccine Antigens.

Thornton RB, Kirkham LS, Corscadden KJ, Wiertsema SP, Fuery A, Jones BJ, Coates HL, Vijayasekaran S, Zhang G, Keil A, Richmond PC.

Clin Vaccine Immunol. 2017 Apr 5;24(4). pii: e00556-16. doi: 10.1128/CVI.00556-16. Print 2017 Apr.

20.

Otitis-Prone Children Produce Functional Antibodies to Pneumolysin and Pneumococcal Polysaccharides.

Kirkham LS, Wiertsema SP, Corscadden KJ, Mateus T, Mullaney GL, Zhang G, Richmond PC, Thornton RB.

Clin Vaccine Immunol. 2017 Mar 6;24(3). pii: e00497-16. doi: 10.1128/CVI.00497-16. Print 2017 Mar.

21.

No evidence for impaired humoral immunity to pneumococcal proteins in Australian Aboriginal children with otitis media.

Thornton RB, Kirkham LS, Corscadden KJ, Coates HL, Vijayasekaran S, Hillwood J, Toster S, Edminston P, Zhang G, Keil A, Richmond PC.

Int J Pediatr Otorhinolaryngol. 2017 Jan;92:119-125. doi: 10.1016/j.ijporl.2016.11.019. Epub 2016 Nov 22.

22.

Cord blood Streptococcus pneumoniae-specific cellular immune responses predict early pneumococcal carriage in high-risk infants in Papua New Guinea.

Francis JP, Richmond PC, Strickland D, Prescott SL, Pomat WS, Michael A, Nadal-Sims MA, Edwards-Devitt CJ, Holt PG, Lehmann D, van den Biggelaar AH.

Clin Exp Immunol. 2017 Mar;187(3):408-417. doi: 10.1111/cei.12902. Epub 2016 Dec 18.

23.

Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial.

Marshall HS, Richmond PC, Beeslaar J, Jiang Q, Jansen KU, Garcés-Sánchez M, Martinón-Torres F, Szenborn L, Wysocki J, Eiden J, Harris SL, Jones TR, Lee SS, Perez JL; 6108A12001 Study Investigators.

Lancet Infect Dis. 2017 Jan;17(1):58-67. doi: 10.1016/S1473-3099(16)30314-0. Epub 2016 Oct 11.

PMID:
27745812
24.

Viral Etiology and the Impact of Codetection in Young Children Presenting With Influenza-Like Illness.

Lim FJ, Wake ZV, Levy A, Tempone S, Moore HC, Richmond PC, de Klerk N, Conway NT, Keil AD, Effler PV, Smith DW, Blyth CC; WAIVE group.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):260-266. doi: 10.1093/jpids/piw042.

PMID:
27440506
25.

Duplex Quantitative PCR Assay for Detection of Haemophilus influenzae That Distinguishes Fucose- and Protein D-Negative Strains.

de Gier C, Pickering JL, Richmond PC, Thornton RB, Kirkham LA.

J Clin Microbiol. 2016 Sep;54(9):2380-3. doi: 10.1128/JCM.00982-16. Epub 2016 Jun 22.

26.

Haemophilus haemolyticus Interaction with Host Cells Is Different to Nontypeable Haemophilus influenzae and Prevents NTHi Association with Epithelial Cells.

Pickering JL, Prosser A, Corscadden KJ, de Gier C, Richmond PC, Zhang G, Thornton RB, Kirkham LA.

Front Cell Infect Microbiol. 2016 May 9;6:50. doi: 10.3389/fcimb.2016.00050. eCollection 2016.

27.

A prospective cohort study assessing the reactogenicity of pertussis and influenza vaccines administered during pregnancy.

Regan AK, Tracey LE, Blyth CC, Richmond PC, Effler PV.

Vaccine. 2016 Apr 29;34(20):2299-304. doi: 10.1016/j.vaccine.2016.03.084. Epub 2016 Mar 31.

PMID:
27038132
28.

Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer.

Kotecha RS, Wadia UD, Jacoby P, Ryan AL, Blyth CC, Keil AD, Gottardo NG, Cole CH, Barr IG, Richmond PC.

Cancer Med. 2016 Feb;5(2):285-93. doi: 10.1002/cam4.596. Epub 2015 Dec 29.

29.

Influenza Vaccine Effectiveness and Uptake in Children at Risk of Severe Disease.

Blyth CC, Jacoby P, Effler PV, Kelly H, Smith DW, Borland ML, Willis GA, Levy A, Keil AD, Richmond PC; WAIVE Study Team.

Pediatr Infect Dis J. 2016 Mar;35(3):309-15. doi: 10.1097/INF.0000000000000999.

PMID:
26646548
30.

The effectiveness of influenza vaccination in preventing hospitalisation in children in Western Australia.

Blyth CC, Cheng AC, Finucane C, Jacoby P, Effler PV, Smith DW, Kelly H, Macartney KK, Richmond PC.

Vaccine. 2015 Dec 16;33(51):7239-7244. doi: 10.1016/j.vaccine.2015.10.122. Epub 2015 Nov 6.

PMID:
26549359
31.

Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: a randomised study.

Torresi J, Heron LG, Qiao M, Marjason J, Chambonneau L, Bouckenooghe A, Boaz M, van der Vliet D, Wallace D, Hutagalung Y, Nissen MD, Richmond PC.

Vaccine. 2015 Sep 22;33(39):5127-34. doi: 10.1016/j.vaccine.2015.08.008. Epub 2015 Aug 13.

32.

Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: a phase III, randomized, multicentre, lot-to-lot consistency study.

Perrett KP, McVernon J, Richmond PC, Marshall H, Nissen M, August A, Percell S, Toneatto D, Nolan T.

Vaccine. 2015 Sep 22;33(39):5217-24. doi: 10.1016/j.vaccine.2015.06.103. Epub 2015 Jul 29.

PMID:
26232542
33.

Human Infant Memory B Cell and CD4+ T Cell Responses to HibMenCY-TT Glyco-Conjugate Vaccine.

Fuery A, Richmond PC, Currie AJ.

PLoS One. 2015 Jul 20;10(7):e0133126. doi: 10.1371/journal.pone.0133126. eCollection 2015.

34.

Comparison of text-messaging to voice telephone interviews for active surveillance of adverse events following immunisation.

Regan AK, Blyth CC, Tracey L, Mak DB, Richmond PC, Effler PV.

Vaccine. 2015 Jul 17;33(31):3689-94. doi: 10.1016/j.vaccine.2015.06.022. Epub 2015 Jun 12.

PMID:
26079616
35.

A prospective cohort study comparing the reactogenicity of trivalent influenza vaccine in pregnant and non-pregnant women.

Regan AK, Tracey L, Blyth CC, Mak DB, Richmond PC, Shellam G, Talbot C, Effler PV.

BMC Pregnancy Childbirth. 2015 Mar 18;15:61. doi: 10.1186/s12884-015-0495-2.

36.

Antibody persistence in Australian adolescents following meningococcal C conjugate vaccination.

Perrett KP, Richmond PC, Borrow R, Nolan T, McVernon J.

Pediatr Infect Dis J. 2015 Mar;34(3):279-85. doi: 10.1097/INF.0000000000000541.

37.

Molecular tools for differentiation of non-typeable Haemophilus influenzae from Haemophilus haemolyticus.

Pickering J, Richmond PC, Kirkham LA.

Front Microbiol. 2014 Dec 2;5:664. doi: 10.3389/fmicb.2014.00664. eCollection 2014. Review.

38.

Using SMS to monitor adverse events following trivalent influenza vaccination in pregnant women.

Regan AK, Blyth CC, Mak DB, Richmond PC, Effler PV.

Aust N Z J Obstet Gynaecol. 2014 Dec;54(6):522-8. doi: 10.1111/ajo.12266. Epub 2014 Oct 11.

PMID:
25306915
39.

Clinical epidemiology and predictors of outcome in children hospitalised with influenza A(H1N1)pdm09 in 2009: a prospective national study.

Khandaker G, Zurynski Y, Ridley G, Buttery J, Marshall H, Richmond PC, Royle J, Gold M, Walls T, Whitehead B, McIntyre P, Wood N, Booy R, Elliott EJ.

Influenza Other Respir Viruses. 2014 Nov;8(6):636-45. doi: 10.1111/irv.12286. Epub 2014 Sep 27.

40.

How Accurate Are International Classification of Diseases-10 Diagnosis Codes in Detecting Influenza and Pertussis Hospitalizations in Children?

Moore HC, Lehmann D, de Klerk N, Smith DW, Richmond PC, Keil AD, Blyth CC.

J Pediatric Infect Dis Soc. 2014 Sep;3(3):255-60. doi: 10.1093/jpids/pit036. Epub 2013 Jul 4.

PMID:
26625389
41.

The impact of pandemic A(H1N1)pdm09 influenza and vaccine-associated adverse events on parental attitudes and influenza vaccine uptake in young children.

Blyth CC, Richmond PC, Jacoby P, Thornton P, Regan A, Robins C, Kelly H, Smith DW, Effler PV.

Vaccine. 2014 Jul 7;32(32):4075-81. doi: 10.1016/j.vaccine.2014.05.055. Epub 2014 May 28.

PMID:
24877764
42.

Effectiveness of trivalent flu vaccine in healthy young children.

Blyth CC, Jacoby P, Effler PV, Kelly H, Smith DW, Robins C, Willis GA, Levy A, Keil AD, Richmond PC; WAIVE Study Team.

Pediatrics. 2014 May;133(5):e1218-25. doi: 10.1542/peds.2013-3707. Epub 2014 Apr 21.

PMID:
24753525
43.

High nasopharyngeal carriage of non-vaccine serotypes in Western Australian aboriginal people following 10 years of pneumococcal conjugate vaccination.

Collins DA, Hoskins A, Bowman J, Jones J, Stemberger NA, Richmond PC, Leach AJ, Lehmann D.

PLoS One. 2013 Dec 3;8(12):e82280. doi: 10.1371/journal.pone.0082280. eCollection 2013.

44.

A practical method for preparation of pneumococcal and nontypeable Haemophilus influenzae inocula that preserves viability and immunostimulatory activity.

Kirkham LA, Corscadden KJ, Wiertsema SP, Currie AJ, Richmond PC.

BMC Res Notes. 2013 Dec 9;6:522. doi: 10.1186/1756-0500-6-522.

45.

Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents.

Lambert SB, Chuk LM, Nissen MD, Nolan TM, McVernon J, Booy R, Heron L, Richmond PC, Walls T, Marshall HS, Reynolds GJ, Hartel GF, Hu W, Lai MH.

Influenza Other Respir Viruses. 2013 Sep;7(5):676-85. doi: 10.1111/irv.12107. Epub 2013 Apr 2.

46.

Safety and immunogenicity of neonatal pneumococcal conjugate vaccination in Papua New Guinean children: a randomised controlled trial.

Pomat WS, van den Biggelaar AH, Phuanukoonnon S, Francis J, Jacoby P, Siba PM, Alpers MP, Reeder JC, Holt PG, Richmond PC, Lehmann D; Neonatal Pneumococcal Conjugate Vaccine Trial Study Team.

PLoS One. 2013;8(2):e56698. doi: 10.1371/journal.pone.0056698. Epub 2013 Feb 22.

47.

Clinical Predictors of Influenza in Young Children: The Limitations of "Influenza-Like Illness".

Conway NT, Wake ZV, Richmond PC, Smith DW, Keil AD, Williams S, Kelly H, Carcione D, Effler PV, Blyth CC; Western Australia Influenza Vaccine Effectiveness (WAIVE) Team.

J Pediatric Infect Dis Soc. 2013 Mar;2(1):21-9. doi: 10.1093/jpids/pis081. Epub 2012 Sep 3.

PMID:
26619439
48.

Safety surveillance of influenza vaccine in pregnant women.

Carcione D, Blyth CC, Richmond PC, Mak DB, Effler PV.

Aust N Z J Obstet Gynaecol. 2013 Feb;53(1):98-9. doi: 10.1111/ajo.12034. No abstract available.

PMID:
23406000
49.

Neutrophil extracellular traps and bacterial biofilms in middle ear effusion of children with recurrent acute otitis media--a potential treatment target.

Thornton RB, Wiertsema SP, Kirkham LA, Rigby PJ, Vijayasekaran S, Coates HL, Richmond PC.

PLoS One. 2013;8(2):e53837. doi: 10.1371/journal.pone.0053837. Epub 2013 Feb 5.

50.

A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults.

Marshall HS, Richmond PC, Nissen MD, Wouters A, Baber J, Jiang Q, Anderson AS, Jones TR, Harris SL, Jansen KU, Perez JL.

Vaccine. 2013 Mar 15;31(12):1569-75. doi: 10.1016/j.vaccine.2013.01.021. Epub 2013 Jan 24.

PMID:
23352429

Supplemental Content

Loading ...
Support Center